| Full Name |
SARS-Associated Coronavirus E
|
Abbreviated Name-1 |
SARS-Associated Coronavirus E; |
| Documents |
|---|
| Figures |
|---|
| Reference |
|---|
Yu IM, et al. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae. J. Biol. Chem. Jun 2006; 281(25): 17134-17139.
Liu J, et al. Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS. Clin Vaccine Immunol. May 2006; 13(5): 594-597.
Liu IJ, et al. Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. J. Clin. Microbiol. May 2005; 43(5): 2444-2448.
|
|
Description |
E. coli derived recombinant. The protein contains the E protein immunodominant regions. |
Purity |
Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ml in 50 mM Tris-HCl, 60 mM NaCl, 50% glycerol. |
Stability |
Five year frozen, 6 month at +4°C. |
Specificity |
Immunoreactive with sera of SARS-infected individuals. |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of SARS with minimal specificity problems. |
Note |
; |
